These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9034758)

  • 1. Low-dose methotrexate in the management of Chinese patients with steroid-dependent asthma.
    Yew WW; Lee J; Wong PC; Wong CF; Chau CH
    Drugs Exp Clin Res; 1996; 22(6):317-21. PubMed ID: 9034758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single, high-dose intramuscular triamcinolone acetonide versus weekly oral methotrexate in life-threatening asthma: a double-blind study.
    Ogirala RG; Sturm TM; Aldrich TK; Meller FF; Pacia EB; Keane AM; Finkel RI
    Am J Respir Crit Care Med; 1995 Nov; 152(5 Pt 1):1461-6. PubMed ID: 7582277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short term effect of methotrexate in severe steroid-dependent asthma.
    Kanzow G; Nowak D; Magnussen H
    Lung; 1995; 173(4):223-31. PubMed ID: 7564481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate therapy of oral corticosteroid-dependent asthmatics reduces serum immunoglobulins: correlation with clinical response to therapy.
    Corrigan CJ; Shiner RJ; Shakur BH; Ind PW
    Clin Exp Allergy; 2005 May; 35(5):579-84. PubMed ID: 15898978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefits of low weekly doses of methotrexate in steroid-dependent asthmatic patients. A double-blind, randomized, placebo-controlled study.
    Comet R; Domingo C; Larrosa M; Morón A; Rué M; Amengual MJ; Marín A
    Respir Med; 2006 Mar; 100(3):411-9. PubMed ID: 16099632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of methotrexate in the management of severe steroid-dependent asthma].
    Rybus L; Droszcz W
    Wiad Lek; 1999; 52(7-8):363-6. PubMed ID: 10540582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weekly low-dose methotrexate for reduction of Global Initiative for Asthma Step 5 treatment in severe refractory asthma: study protocol for a randomized controlled trial.
    Polosa R; Bellinvia S; Caruso M; Emma R; Alamo A; Kowalski ML; Domingo C
    Trials; 2014 Dec; 15():492. PubMed ID: 25523634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long term and low dose treatment with methotrexate in corticosteroid-dependent asthma--two-year clinical experience].
    Liang TW; Tsai JJ; Wang SR
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Nov; 25(4):264-9. PubMed ID: 1342643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate in the management of severe steroid dependent asthma.
    Taylor DR; Flannery EM; Herbison GP
    N Z Med J; 1993 Sep; 106(964):409-11. PubMed ID: 8377957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of methotrexate for treatment of corticosteroid-dependent asthma].
    Kazimierczak A; Maziarka D; Skorupa W; Kuś J
    Pneumonol Alergol Pol; 1997; 65(3-4):225-30. PubMed ID: 9489419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose methotrexate spares steroid usage in steroid-dependent asthmatic patients: a meta-analysis.
    Marin MG
    Chest; 1997 Jul; 112(1):29-33. PubMed ID: 9228353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of methotrexate 30 mg per week with placebo in chronic steroid-dependent asthma: a 12-week double-blind, cross-over study.
    Trigg CJ; Davies RJ
    Respir Med; 1993 Apr; 87(3):211-6. PubMed ID: 8497701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate for lung transplant recipients with steroid-resistant acute rejection.
    Cahill BC; O'Rourke MK; Strasburg KA; Savik K; Jessurun J; Bolman RM; Hertz MI
    J Heart Lung Transplant; 1996 Nov; 15(11):1130-7. PubMed ID: 8956122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilot study of low dose oral methotrexate treatment for primary biliary cirrhosis.
    Bergasa NV; Jones A; Kleiner DE; Rabin L; Park Y; Wells MC; Hoofnagle JH
    Am J Gastroenterol; 1996 Feb; 91(2):295-9. PubMed ID: 8607496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate in the treatment of corticosteroid-dependent asthma. A double-blind crossover study.
    Mullarkey MF; Blumenstein BA; Andrade WP; Bailey GA; Olason I; Wetzel CE
    N Engl J Med; 1988 Mar; 318(10):603-7. PubMed ID: 3278232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised, double-blind, placebo-controlled trial of methotrexate in steroid-dependent asthma.
    Shiner RJ; Nunn AJ; Chung KF; Geddes DM
    Lancet; 1990 Jul; 336(8708):137-40. PubMed ID: 1973472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twelve years' experience with methotrexate for GINA treatment step 5 asthma patients.
    Domingo C; Moreno A; Amengual MJ; Comet R; Luján M
    Curr Med Res Opin; 2009 Feb; 25(2):367-74. PubMed ID: 19192981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of the steroid-sparing response to low-dose methotrexate on bone metabolism in glucocorticoid-dependent asthmatics.
    Girgis SI; Nwokeji A; Shakur BH; Ind PW; Shiner RJ
    Clin Chim Acta; 2004 Mar; 341(1-2):157-63. PubMed ID: 14967172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Methotrexate in the treatment of asthma. Open trial in 10 corticoid-dependent patients with severe asthma].
    Becquart LA; Wallaert B; Lassalle P; Guéné-Ribassin C; Tonnel AB
    Rev Mal Respir; 1994; 11(6):565-71. PubMed ID: 7831506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind, placebo-controlled study of cyclosporin A as a corticosteroid-sparing agent in corticosteroid-dependent asthma.
    Lock SH; Kay AB; Barnes NC
    Am J Respir Crit Care Med; 1996 Feb; 153(2):509-14. PubMed ID: 8564089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.